BOVIMUN NEO

• One dose of the vaccine (2.0 ml) contains:
• Active ingredients:
• Cattle rotavirus, strain RP-182 ≥ 7,0 lg TCID50;
• Cattle coronavirus, strain CV-315 ≥ 256 HAU;
• Escherichia coli, strain EC18 ≥ 9.0 lg CFU;
• Clostridium perfringens type С, strain Cl.p.-19, toxoid ≥ 20.0 IU
• Excipients: adjuvant Aerosil A-300 – 10 mg.

• Suspension.

• The vaccine forms specific immunity to the causative agents of rotavirus infection, coronavirus infection, Escherichia coli, and clostridial diseases in vaccinated cows (or heifers) after double immunization. The formed antibodies are transmitted with colostrum and provide passive protection of newborn calves from rotavirus infection, coronavirus infections, Escherichia coli, and clostridial diseases up to 45 days of age. The vaccine has no therapeutic properties.

• Cattle.

• Prevention of diarrhea in newborn calves caused by rotavirus, coronavirus infections, Escherichia coli with adhesion factor K99, and Clostridium perfringens type C.

• The vaccine is only used in clinically healthy animals. It is not allowed to vaccinate emaciated animals and animals under stress, caused by transportation, exposure to extreme environmental conditions, helminth infestation, or other immunosuppressive states.
• An intense immune response may not be present if the vaccine has not been used as indicated in the leaflet.

• The rules of asepsis must be followed. The vaccine in the vial should be used within 3 hours after the first withdrawal.

• There is no data on the safety and efficacy of the drug with other drugs, therefore, the simultaneous use of BOVIMUN NEO vaccine with other therapeutic and/or prophylactic drugs is not recommended.

• The vaccine is administered to pregnant cows and heifers in the recommended doses.